Debbie's Place

A Patient's Point of View




Effects of cannabidiol derivatives on intestinal motility                    (abst – undated)


Some actions of delta-1 tetrahydrocannabinol and cannabidiol at cholinergic junctions. (full – 1971)                             


The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice (full – 1973)                              


Intestinal obstruction by an unusual foreign body                     (full – 1973)


Psychoactive Cannabinoids Reduce Gastrointestinal Propulsion and Motility in Rodents (full – 1989)                               


Inhibitory effect of cannabinoid agonists on gastric emptying in the rat                   (abst – 1999)


The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats (abst – 1999)                               


Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil                                                        (full – 2000)


Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea-pig ileum (full – 2000)                            


Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats (abst – 2000)                                 


Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats (abst – 2000)                                   


Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation                                                       (full – 2001)


Cannabinoids and the gastrointestinal tract                     (full – 2001)


Patent 6410588  Use of cannabinoids as anti-inflammatory agents                      (full – 2002)


Endocannabinoids as physiological regulators of colonic propulsion in mice. (abst – 2002)                                



Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon        (full – 2003)


Cannabinoids for gastrointestinal diseases: potential therapeutic applications (abst – 2003)                            


Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.            (full – 2004)                     


Cannabinoids and intestinal motility: welcome to CB2 receptors                 (full – 2004)


Involvement of cannabinoid receptors in gut motility and visceral perception. (full – 2004)                          


Effect of ethanol extracts of three Chinese medicinal plants with laxative properties on ion transport of the rat intestinal epithelia.                                                     (full – 2004)


The endogenous cannabinoid system protects against colonic inflammation

(full – 2004)  


Cannabinoids cool the intestine               (full – 2004)


Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats                                                                  (full – 2004)


Involvement of cannabinoid receptors in gut motility and visceral perception (full – 2004)                       


Fibromyalgia, IBS, and the Endocannabinoid-CB-Receptor (ECBR) system (abst – 2004)                          


Cannabinoids spell relief in colon inflammation                 (news – 2004)


The effects of Δ9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide                                                           (full – 2005)


Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs. (full – 2005)                         


Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P                                                                    (full – 2005)


Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.                                               (abst – 2005) 


Differential Expression of Cannabinoid Receptors in the Human Colon: Cannabinoids Promote Epithelial Wound Healing                                                              (abst – 2005)


Cannabis drugs may benefit those with bowel disease              (news – 2005)


Cannabis may soothe inflamed bowels                (news – 2005)


Bowel Study Backs Cannabis Drugs               (news – 2005)


Cannabis-Based Drugs Could Aid in Treating Bowel Disease                (news – 2005)


Cannabinoid 1 (CB1) receptors coupled to cholinergic motorneurones inhibit neurogenic circular muscle contractility in the human colon.                                          (full – 2006)


Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.                                                                      (full – 2006)


Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation.                                                     (full – 2006)


Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P                                                                        (full – 2006)


Endocannabinoid overactivity and intestinal inflammation                (full – 2006)


Endocannabinoids and the gastrointestinal tract.             (abst – 2006)


Cannabinoids promote survival of normal human colonic epithelial cells (#334) (abst – 2006)                         


Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study                                                          (abst – 2006)


Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions.        (abst – 2006)                     


Science: Cannabinoids reduce inflammation of the bowel in animal model   (news – 2006)


Synthetic THC Eases Stomach Cramping, Study Says               (news – 2006)


ACG: Cannabinoid Activator Mellows Out Colon             (news – 2006)


Cannabis Helps Ulcers And Crohn’s Disease               (news – 2006)


Cannabis Drugs “May control Symptoms of Gut Disease”                (news – 2006)


Cannabis Chemicals May Alleviate Post-Eating Stomach Cramps                (news – 2006)  Cramps-15219-1/


Endocannabinoids and the gastrointestinal tract: what are the key questions? (full – 2007)                         


Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.    (full – 2007)


The endogenous cannabinoid system: a new player in the brain-gut-adipose axis (full – 2007)


Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study                                                     (full – 2007)


Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation     (full – 2007)


Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats. (abst – 2007)                                   


The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.  (abst – 2007)


Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats                                        (full – 2008)


Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.    (full – 2008)


Effect of Δ9-tetrahydrocannabinol, a cannabinoid receptor agonist, on the triggering of transient lower oesophageal sphincter relaxations in dogs and humans (full – 2008)


Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice       (full – 2008)


Cannabinoid CB1 Receptors Are Expressed by Parietal Cells of the Human Gastric Mucosa        (full – 2008)                 


The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet.          (full – 2008)


Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation.           (full – 2008)                   


Anti-inflammatory cannabinoids in diet              (full – 2008)


Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects      (abst – 2008)                


Cannabinoids and gastrointestinal motility: animal and human studies.              (abst – 2008) testinal_motility:_animal_and_human_studies_


Gastrointestinal endocannabinoid system: multifaceted roles in the healthy and inflamed intestine          (abst – 2008)       


Anti-inflammatory compound from cannabis found in herbs             (news – 2008)


Science: THC reduces reflux of acid from the stomach                (news – 2008)


Gastrointestinal Disorders and Medical Marijuana                (full – 2008)


Salutary pizza spice             (news – 2008)


Cannabinoid-1 (CB1) receptors regulate colonic propulsion by acting at motor neurons within the ascending motor pathways in mouse colon                                                              (full – 2009) text=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT


Interaction between cannabinoid CB1 receptors and endogenous ATP in the control of spontaneous mechanical activity in mouse ileum.                                                        (full – 2009)


Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids. (full – 2009)                                 


Endocannabinoids and the gastrointestinal tract: what are the key questions?

(full – 2009)      


Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception          (full – 2009)


Cannabinoids as novel anti-inflammatory drugs.              (full – 2009)


Involvement of nitric oxide in the gastroprotective effect of ACEA, a selective cannabinoid CB1 receptor agonist, on aspirin-induced gastric ulceration.                                                                      (abst – 2009)


Cannabinoids in intestinal inflammation and cancer.              (abst – 2009)   nel.Pubmed_RVDocSum&ordinalpos=22


Medical Marijuana and Gastritis                (news – 2009)


Cannabis for Ulcerative Colitis and Crohn’s Disease treatment               (news – 2009)  treatment.aspx


Medical Marijuana and Diverticulitis                 (news – 2009)


Gastrointestinal Disorders                    (news – 2009)


Medical Marijuana and Constipation                 (news – 2009)


The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn’s Disease                                                        (full – 2010)


The endocannabinoid system links gut microbiota to adipogenesis              (full – 2010)


Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus. (full – 2010)




Cannabinoids and the gut: New developments and emerging concepts.           (abst – 2010)


Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability.        (abst – 2010)                


Gut feelings about the endocannabinoid system              (full – 2011)


Treatment of Crohn’s disease with cannabis: an observational study.               (full – 2011)


Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis (full – 2011)                        


Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation.   (full – 2011)


Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                          


Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.       (full – 2011)                              


A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents.        (abst – 2011)            


Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation.                                      (abst – 2011)


Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases.  (abst – 2011)


The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus.                                                        (abst – 2011)   cid_and_cannabidiol_on_contractility_of_the_gastrointestinal_tract_of_Suncus_murinus_




Effects of Cannabinoid Agonists on Sheep Sphincter of Oddi in vitro.            (abst – 2011)


Inhibition of cannabinoid metabolic enzymes reduces NSAID-induced gastric pathology (abst – 2011)  RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype



Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability. (abst – 2011)                          


Surgery REVERSED by Cannabis Oil from vaporizer!               (anecdotal – 2011)


“THC Oil Is Saving The Life of My Sister”                 (anecdotal – 2011)


The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility.             (full – 2012)


The JNK inhibitor XG-102 protects against TNBS-induced colitis.  (full – 2012)


Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.                                                        (abst – 2012)


Cannabinoid signalling regulates inflammation and energy balance: The importance of the brain-gut axis.                                          (abst – 2012)



Genetic Epidemiology and Pharmacogenetics in Irritable Bowel Syndrome. (abst – 2012)                              


The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention. (abst – 2012)                           


Effects of palmitoylethanolamide on intestinal injury and inflammation caused by ischemia-reperfusion in mice                                                                (abst – 2012)  cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT


Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice.  (abst – 2012)                                       


The effects of fasting duration on gastric emptying in man, an exploration of the role of the endocannabinoid system and inter-individual responsiveness                                                   (abst – 2012)


Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility.                                                          (abst – 2012)


The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                                                     (abst – 2012)


A potential role for GPR55 in gastrointestinal functions.             (abst – 2012)


The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                                                     (abst – 2012)


Endocannabinoid modulation of jejunal afferent responses to LPS               (abst – 2012)


Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.                                                                   (abst – 2012)


Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis.                                     (abst – 2012)


Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects.

(abst – 2013)      



Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits.           (abst – 2013)                                  

Share a link for

1 Comment

  1. I couldn’t refrain from commenting. Exceptionally well written!

Leave a Reply

Your email address will not be published.


© 2019 Debbie's Place

Powered by